Enzo Clinical Labs, INC.

Enzo Clinical Labs, INC. was paid $26.17M by Medicaid between Jan 2018 and Jul 2023, across 320 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 28% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in New York

Rank by total paid#15 of 116

Median peer was paid$618K

This provider vs. median42×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	308,528	$2.62M
2019	381,866	$3.02M
2020	452,672	$4.53M
2021	587,682	$8.28M
2022	531,943	$6.16M
2023	194,011	$1.56M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	28%	139,847	87,726	$7.44M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	5.5%	76,631	51,478	$1.44M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	4.1%	75,533	74,241	$1.06M
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	4.0%	59,406	59,166	$1.04M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	3.5%	75,478	74,190	$927K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	2.7%	18,149	16,187	$709K
80050	General health panel	2.4%	38,563	38,407	$616K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	2.2%	37,182	37,009	$584K
86480		2.0%	15,487	15,415	$512K
80053	Comprehensive metabolic panel	1.9%	82,225	81,422	$490K
83036	Hemoglobin; glycosylated (A1C)	1.7%	83,734	83,375	$454K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	1.6%	32,773	32,068	$411K

308 more codes

80061	Lipid panel	1.5%	103,614	$391K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	1.4%	2,015	$376K
88142		1.3%	29,311	$347K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	1.3%	18,759	$331K
84443	Thyroid stimulating hormone (TSH)	1.3%	61,504	$329K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	1.2%	66,403	$304K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	1.1%	31,342	$293K
86769		1.0%	10,493	$273K
87481		<1%	17,472	$255K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	7,498	$249K
82607		<1%	36,331	$246K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	99,736	$224K
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	<1%	1,056	$220K
82746		<1%	30,651	$200K
84439		<1%	43,886	$191K
87086	Culture, bacterial; quantitative colony count, urine	<1%	47,601	$155K
82670		<1%	10,394	$149K
81001		<1%	79,847	$143K
86003		<1%	4,188	$142K
87340		<1%	29,064	$136K
86803		<1%	25,756	$134K
86696		<1%	13,239	$133K
84403		<1%	9,368	$125K
83001		<1%	12,467	$123K
84153		<1%	11,887	$122K
84144		<1%	10,846	$116K
84702		<1%	15,331	$114K
83002		<1%	11,630	$114K
86706		<1%	23,796	$110K
84146		<1%	9,639	$108K
82728		<1%	15,649	$103K
86762		<1%	12,453	$91K
88342		<1%	2,724	$89K
84402		<1%	6,257	$81K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	2,152	$79K
86618		<1%	5,223	$79K
87653		<1%	5,637	$76K
86765		<1%	11,261	$75K
88365		<1%	1,999	$75K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	6,840	$73K
88112		<1%	3,259	$67K
86787		<1%	13,401	$66K
83970		<1%	2,980	$63K
84550		<1%	26,252	$61K
86780		<1%	10,008	$61K
84480		<1%	12,923	$59K
87186		<1%	17,917	$57K
88304		<1%	5,725	$56K
83020		<1%	8,343	$55K
86376		<1%	7,104	$54K
83013		<1%	1,463	$54K
86735		<1%	10,751	$54K
88141		<1%	7,498	$54K
84481		<1%	9,641	$53K
83550		<1%	17,193	$53K
82043		<1%	20,261	$51K
86695		<1%	12,819	$51K
86708		<1%	9,091	$50K
88341		<1%	1,207	$50K
83540		<1%	19,395	$49K
86747		<1%	3,941	$49K
86800		<1%	6,583	$49K
84436		<1%	12,510	$46K
82627		<1%	3,878	$44K
83655		<1%	5,942	$44K
87070		<1%	16,636	$44K
87480		<1%	4,979	$43K
86592		<1%	21,929	$42K
82248		<1%	17,298	$42K
86704		<1%	8,094	$40K
80048	Basic metabolic panel (calcium, ionized)	<1%	8,651	$39K
80055		<1%	2,292	$39K
84154		<1%	3,675	$39K
86709		<1%	7,344	$38K
87510		<1%	4,819	$38K
88184		<1%	2,041	$35K
83880		<1%	1,772	$34K
82105		<1%	6,454	$32K
81329		<1%	988	$32K
82784		<1%	2,698	$30K
86235		<1%	1,686	$30K
82652		<1%	4,043	$29K
83615		<1%	10,115	$28K
86038		<1%	7,648	$27K
88187		<1%	2,038	$27K
80164		<1%	2,685	$26K
87486		<1%	2,362	$26K
87581		<1%	2,361	$26K
81422		<1%	560	$26K
84479		<1%	9,384	$24K
81401		<1%	554	$24K
86225		<1%	5,007	$23K
86850		<1%	6,848	$23K
83498		<1%	1,565	$22K
87088		<1%	6,197	$22K
80074		<1%	2,017	$22K
83735		<1%	7,714	$21K
82785		<1%	3,059	$21K
87081		<1%	8,155	$21K
86160		<1%	2,070	$21K
86666		<1%	1,316	$20K
84100		<1%	9,045	$19K
87522	Neg quan hep c or qual rna	<1%	999	$19K
82570		<1%	6,968	$19K
86431		<1%	7,421	$19K
86665		<1%	1,205	$19K
81243		<1%	1,789	$18K
86617		<1%	1,035	$18K
88185		<1%	2,040	$18K
87625		<1%	6,576	$18K
86141		<1%	3,156	$18K
86140		<1%	7,322	$17K
82977		<1%	6,472	$17K
85027		<1%	5,251	$17K
86901		<1%	10,671	$17K
86777		<1%	2,426	$16K
86644		<1%	2,325	$16K
82626		<1%	1,278	$16K
84156		<1%	7,114	$15K
86900		<1%	10,553	$15K
87517		<1%	2,731	$15K
81361		<1%	283	$15K
81400		<1%	947	$14K
86778		<1%	2,104	$14K
84460		<1%	6,352	$14K
87350		<1%	2,675	$14K
83516		<1%	2,174	$14K
86707		<1%	2,636	$13K
84270		<1%	1,573	$13K
82378		<1%	1,277	$13K
87631		<1%	482	$13K
83525		<1%	2,154	$12K
86645		<1%	2,001	$12K
86304		<1%	1,346	$12K
81402		<1%	441	$12K
85730		<1%	3,451	$11K
82533		<1%	1,333	$11K
85610		<1%	5,075	$11K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	272	$11K
81205		<1%	772	$10K
36415	Collection of venous blood by venipuncture	<1%	53,588	$10K
83690		<1%	3,404	$10K
82950		<1%	4,396	$10K
82150		<1%	3,919	$10K
83090		<1%	1,049	$10K
86334		<1%	634	$9K
86200		<1%	2,396	$9K
84432		<1%	2,091	$9K
87341		<1%	1,672	$9K
84445		<1%	958	$9K
81251		<1%	943	$9K
82274		<1%	3,301	$9K
87077		<1%	2,360	$8K
82397		<1%	2,558	$8K
84450		<1%	6,019	$8K
85652		<1%	7,541	$8K
84075		<1%	4,885	$8K
82951		<1%	1,854	$8K
82550		<1%	2,521	$8K
81330		<1%	864	$7K
81200		<1%	926	$7K
86255		<1%	1,328	$7K
80081		<1%	1,060	$7K
80076		<1%	1,749	$7K
81255		<1%	963	$7K
81443		<1%	40	$6K
86757		<1%	181	$6K
82247		<1%	5,115	$6K
81290		<1%	864	$6K
81250		<1%	708	$6K
86664		<1%	815	$6K
84482		<1%	1,366	$6K
81209		<1%	838	$6K
82310		<1%	2,779	$5K
81260		<1%	941	$5K
86039		<1%	1,429	$5K
82947		<1%	4,040	$5K
83698		<1%	682	$5K
87147		<1%	5,184	$5K
81242		<1%	854	$5K
86147		<1%	292	$5K
84560		<1%	1,888	$5K
84540		<1%	1,862	$5K
84425		<1%	666	$5K
86663		<1%	816	$5K
84466		<1%	614	$5K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	80	$5K
84207		<1%	343	$5K
83080		<1%	343	$5K
86753		<1%	540	$4K
87255		<1%	481	$4K
81596		<1%	119	$4K
87109		<1%	607	$4K
87536		<1%	85	$4K
82677		<1%	354	$4K
80178		<1%	659	$4K
81257		<1%	225	$4K
85651		<1%	2,357	$4K
82565		<1%	2,717	$4K
86060		<1%	1,170	$4K
81015		<1%	3,205	$4K
84590		<1%	572	$3K
86337		<1%	446	$3K
87177		<1%	694	$3K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	459	$3K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	107	$3K
85045		<1%	1,490	$3K
82465		<1%	2,017	$3K
87209		<1%	697	$3K
82040		<1%	1,940	$3K
84520		<1%	2,215	$3K
82374		<1%	2,076	$3K
86631		<1%	225	$3K
84132		<1%	1,754	$2K
82435		<1%	2,127	$2K
86317		<1%	465	$2K
86162		<1%	258	$2K
87075		<1%	744	$2K
82672		<1%	235	$2K
84155		<1%	2,130	$2K
83695		<1%	856	$2K
84295		<1%	1,587	$2K
83527		<1%	316	$2K
83700		<1%	599	$2K
86301		<1%	258	$2K
86677		<1%	338	$2K
84165		<1%	435	$2K
87210		<1%	1,013	$2K
81232		<1%	26	$2K
86336		<1%	276	$2K
83021		<1%	148	$2K
86300		<1%	162	$2K
82985		<1%	300	$2K
84703		<1%	813	$2K
87529		<1%	56	$1K
87184		<1%	1,381	$1K
83010		<1%	190	$1K
86609		<1%	177	$1K
84681		<1%	131	$1K
86632		<1%	168	$1K
82952		<1%	1,104	$1K
84163		<1%	132	$1K
83520		<1%	432	$1K
82180		<1%	230	$985.84
82164		<1%	202	$942.24
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	94	$921.30
86146		<1%	56	$899.13
81374		<1%	102	$858.98
87046		<1%	133	$855.46
82172		<1%	87	$719.66
87045		<1%	146	$629.53
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	19	$615.61
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	41	$572.92
84446		<1%	69	$532.17
85007		<1%	899	$496.25
83883		<1%	171	$491.41
87254		<1%	60	$456.91
82380		<1%	246	$429.28
86308		<1%	153	$427.86
86161		<1%	69	$389.04
87449		<1%	72	$376.52
87299		<1%	35	$352.54
87205		<1%	222	$330.39
82525		<1%	44	$316.92
82747		<1%	59	$302.16
86021		<1%	43	$299.42
84630		<1%	69	$295.89
87275		<1%	35	$278.31
87276		<1%	35	$278.31
82595		<1%	83	$272.59
82787		<1%	28	$269.93
84255		<1%	30	$246.36
87338		<1%	55	$242.27
82390		<1%	51	$237.20
80177		<1%	25	$211.88
83921		<1%	14	$200.22
87279		<1%	35	$200.13
87260		<1%	35	$200.13
87280		<1%	35	$200.13
85660		<1%	155	$194.53
87101		<1%	81	$183.90
88312		<1%	13	$172.01
82157		<1%	12	$163.96
88173		<1%	14	$162.82
84478		<1%	510	$147.10
86148		<1%	13	$142.39
84252		<1%	55	$120.94
82542		<1%	16	$86.45
86008		<1%	16	$81.06
85280		<1%	12	$75.30
85270		<1%	12	$69.63
85260		<1%	12	$69.63
81003		<1%	69	$63.88
82340		<1%	24	$56.03
87102		<1%	26	$53.20
82103		<1%	14	$51.76
85018		<1%	117	$46.37
83088		<1%	13	$45.71
87185		<1%	29	$45.27
85041		<1%	79	$44.76
82270		<1%	19	$44.35
85240		<1%	12	$39.88
87150		<1%	37	$35.09
83718		<1%	450	$31.13
85014		<1%	79	$30.81
87076		<1%	14	$18.34
87207		0%	12	$0.00
83704		0%	27	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSCHAPFEL, DIETER (CHIEF SCIENTIFIC OFFICER/MEDICAL DI)